Table 2.
The details of the included studies.
| Studies | Study location | Sample size | Age (T/C) | BMI (kg/m2) (T/C) | Intervention | Course of treatment | Outcomes | ||
|---|---|---|---|---|---|---|---|---|---|
| T | C | T | C | ||||||
| Zhao Shuai 2021 | Shandong province, China | 60 | 60 | 32.22 ± 4.35/30.80 ± 4.69 | 28.05 ± 1.88/28.63 ± 2.78 | CFDTD + Western medicine | Placebo + Western medicine | 21 days | ①④ |
| Lian Fang 2020 | Shandong province, China | 33 | 33 | 30.00 ± 3.07/29.70 ± 3.74 | — | CFDTD + Western medicine | Placebo + Western medicine | 21 days | ①③ |
| Liu Shang 2021 | Zhejiang province, China | 98 | 98 | 27.60 ± 3.50/27.80 ± 3.30 | — | CFDTD + Western medicine | Western medicine | 3 months | ①②③⑥ |
| Lin Haiyu 2020 | Shandong province, China | 40 | 40 | 31.19 ± 5.42/31.04 ± 5.31 | — | CFDTD + Western medicine | Western medicine | 30 days | ①③⑥ |
| Huang Dingfang 2018 | Jiangxi province, China | 42 | 42 | 24.87 ± 4.67/24.59 ± 4.92 | 32.20 ± 4.23/31.32 ± 4.65 | CFDTD + Western medicine | Western medicine | 3 months | ①②⑥ |
| Zeng Wen 2017 | Hunan province, China | 60 | 60 | 32.35 ± 5.64/32.23 ± 5.60 | — | CFDTD + Western medicine | Western medicine | 4 months | ①②③④ |
| Chen Jianhong 2014 | Zhejiang province, China | 24 | 24 | 28.50 ± 8.90/27.20 ± 8.50 | — | CFDTD + Western medicine | Western medicine | 6 months | ①②③⑥ |
| Dai Yanhong 2020 | Henan province, China | 46 | 46 | 29.62 ± 3.57/29.84 ± 3.32 | — | CFDTD + Western medicine | Western medicine | 4 months | ①③ |
| Gui Hua 2018 | Zhejiang province, China | 35 | 35 | 28.12 ± 2.23/27.56 ± 2.31 | 22.24 ± 1.18/22.15 ± 1.24 | CFDTD + Western medicine | Western medicine | 4 months | ①③ |
| Li Dejun 2018 | Xinjiang Uygur autonomous region, China | 124 | 124 | 25.64 ± 1.30/26.17 ± 1.82 | — | CFDTD + Western medicine | Western medicine | 3 months | ①⑥ |
| Zhang Qiuzi 2019 | Fujian province, China | 38 | 38 | 27.50 ± 3.60/28.40 ± 5.60 | 25.70 ± 2.52/25.02 ± 2.96 | CFDTD + Western medicine | Western medicine | 3 months | ①②③⑥ |
| Wang Shuqin 2019 | Henan province, China | 57 | 56 | 31.46 ± 4.43/31.51 ± 4.40 | 22.18 ± 1.02/22.43 ± 1.01 | CFDTD + Western medicine | Western medicine | 3 months | ①③⑥ |
| Tong Xingli 2020 | Jiangsu province, China | 30 | 30 | 28.80 ± 3.43/29.57 ± 2.61 | 26.50 ± 1.14/27.23 ± 1.83 | CFDTD + Western medicine | Western medicine | 3 months | ①⑤⑥ |
| Fu Yanping 2021 | Hunan province, China | 30 | 30 | 27.87 ± 3.93/28.07 ± 3.81 | — | CFDTD | Western medicine | 3 months | ①②⑥ |
T: Treatment group; C: Control group; —: Unreported; ①: Pregnancy rate; ②: Ovulation rate; ③: Reproductive Hormones; ④: Glucose Metabolism; ⑤: Lipid Metabolism; ⑥: Incidence of adverse reactions; CFDTD: Cangfu Daotan Decoction.